文献速递关节外科

阿片类药物在全关节置换术中的疗效与安全性:系统综述与直接荟萃分析

The Efficacy and Safety of Opioids in Total Joint Arthroplasty: Systematic Review and Direct Meta-Analysis.
PubMed 文献 · J Arthroplasty · 2020-05-27

该系统综述与直接荟萃分析评估了阿片类药物在初次全关节置换术(TJA)中的疗效与安全性,以支持美国髋膝关节外科医师协会等五家学会的联合临床实践指南。结果显示,术前使用阿片类药物会增加术后阿片类药物消耗量、并发症风险、慢性阿片类药物使用风险并降低患者报告结局;定时预防性、术中或术后使用阿片类药物可减少突破性疼痛所需的额外阿片类药物;出院时减少阿片类药物处方量可获得相当的功能结局并降低阿片类药物消耗;曲马多可减少术后阿片类药物消耗但增加术后恶心、呕吐、口干和头晕风险。结论为中等证据支持在TJA中使用阿片类药物以减轻术后疼痛和阿片类药物消耗,但应谨慎使用,因其可能增加呼吸抑制和镇静等并发症风险,尤其在与其它中枢神经系统抑制剂联用或用于老年人时。

要点

  • 术前使用阿片类药物会导致TJA术后阿片类药物消耗量和并发症增加,并增加慢性阿片类药物使用风险及降低患者报告结局。
  • 定时预防性、术中或术后使用阿片类药物可减少突破性疼痛所需的额外阿片类药物。
  • 出院时减少阿片类药物处方量可获得相当的功能结局并降低阿片类药物消耗。

核心结论

  • 中等证据支持在TJA中使用阿片类药物以减轻术后疼痛和阿片类药物消耗。
  • 阿片类药物应谨慎使用,因其可能增加呼吸抑制和镇静等并发症风险,尤其在与其它中枢神经系统抑制剂联用或用于老年人时。

研究设计与样本

  • 所有纳入研究经过定性和定量 homogeneity 检验,随后进行系统综述和直接比较荟萃分析以评估阿片类药物的疗效和安全性。

主要发现

  • 术前使用阿片类药物导致TJA术后阿片类药物消耗量和并发症增加,并增加慢性阿片类药物使用风险和降低患者报告结局。
  • 定时预防性、术中或术后使用阿片类药物减少突破性疼痛所需的额外阿片类药物。
  • 出院时减少阿片类药物处方量与相当的功能结局和降低的阿片类药物消耗相关。
  • 曲马多减少术后阿片类药物消耗但增加术后恶心、呕吐、口干和头晕风险。

临床怎么用

  • 在TJA围手术期可考虑使用阿片类药物以减轻术后疼痛和阿片类药物消耗,但需谨慎评估风险与获益。
  • 对于术前使用阿片类药物的患者,应警惕术后阿片类药物消耗量增加、并发症风险增高及患者报告结局较差。
  • 出院时应尽量减少阿片类药物处方量,以降低阿片类药物消耗而不影响功能结局。
  • 使用曲马多时需注意其可能增加的术后恶心、呕吐、口干和头晕风险。
  • 阿片类药物应避免与其它中枢神经系统抑制剂联用,老年患者尤需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Opioids are frequently used to treat pain after total joint arthroplasty (TJA). The purpose of this study was to evaluate the efficacy and safety of opioids in primary TJA to support the combined clinical practice guidelines of the American Association of Hip and Knee Surgeons, American Academy of Orthopaedic Surgeons, Hip Society, Knee Society, and the American Society of Regional Anesthesia and Pain Management. METHODS: The MEDLINE, EMBASE, and Cochrane Central Register of controlled trials were searched for studies published before November 2018 on opioids in TJA. All included studies underwent qualitative and quantitative homogeneity testing followed by a systematic review and direct comparison meta-analysis to assess the efficacy and safety of opioids. RESULTS: Preoperative opioid use leads to increased opioid consumption and complications after TJA along with a higher risk of chronic opioid use and inferior patient-reported outcomes. Scheduled opioids administered preemptively, intraoperatively, or postoperatively reduce the need for additional opioids for breakthrough pain. Prescribing fewer opioid pills after discharge is associated with equivalent functional outcomes and decreased opioid consumption. Tramadol reduces postoperative opioid consumption but increases the risk of postoperative nausea, vomiting, dry mouth, and dizziness. CONCLUSION: Moderate evidence supports the use of opioids in TJA to reduce postoperative pain and opioid consumption. Opioids should be used cautiously as they may increase the risk of complications, such as respiratory depression and sedation, especially if combined with other central nervous system depressants or used in the elderly.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Hannon CP, Fillingham YA, Nam D, et al. The Efficacy and Safety of Opioids in Total Joint Arthroplasty: Systematic Review and Direct Meta-Analysis. J Arthroplasty. 2020. PMID: 32571589. doi:10.1016/j.arth.2020.05.032

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。